Amarin Corp Plc (AMRN)

[amarininvestor]

Here is another recent case that is ongoing:

Markman blog on a NVS patent
This part is interesting:
"To that end, numerous generics filed petitions for inter partes review (IPR) with the PTAB that each challenged the validity of the ’405 patent. Those IPRs were consolidated into one, and in July 2018, the PTAB issued a Final Written Decision upholding the validity of the ‘405 patent."

So It seems that one potential path forward is for Amarin to ask revalidation of their patents to the USPTO

Can someone with legal background confirm if I am understanding this correctly based on my reading of this blog on a different case?